Showing results (181-190 of 284) with videos related to

Sort By:
Pageof 29
Journal of Virology|October 19, 2023
Discovery of Nanosota-2, -3, and -4 as super potent and broad-spectrum therapeutic nanobody candidates against COVID-19Gang Ye, Ruangang Pan, Fan Bu, et al.
Plos Pathogens|January 26, 2018
MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infectionJavier Canton, Anthony R Fehr, Raúl Fernandez-Delgado, et al.
Mbio|December 21, 2023
Potent 3CLpro inhibitors effective against SARS-CoV-2 and MERS-CoV in animal models by therapeutic treatmentPengfei Li, Yunjeong Kim, Chamandi S Dampalla, et al.
Biochimica Et Biophysica Acta|March 19, 2013
Crystal structure-based exploration of the important role of Arg106 in the RNA-binding domain of human coronavirus OC43 nucleocapsid proteinI-Jung Chen, Jeu-Ming P Yuann, Yu-Ming Chang, et al.
Virus Research|November 15, 2016
Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse modelAdriaan H de Wilde, Darryl Falzarano, Jessika C Zevenhoven-Dobbe, et al.
Vaccines|July 27, 2022
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y<sub>MA30</sub> Strain of SARS-CoV-2Karen V Kibler, Mateusz Szczerba, Douglas Lake, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2021
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y <sub>MA30</sub> strain of SARS-CoV-2Karen V Kibler, Mateusz Szczerba, Douglas Lake, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug LimitationsAbhishek Kumar Verma, Shea Lowery, Li-Chin Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2024
Evidence of antigenic drift in the fusion machinery core of SARS-CoV-2 spikeTimothy J C Tan, Abhishek K Verma, Abby Odle, et al.
Journal of Virology|January 23, 2015
Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidatesJose A Regla-Nava, Jose L Nieto-Torres, Jose M Jimenez-Guardeño, et al.
Pageof 29